Stelios Papadopoulos
Insider Reports History
- Location
- Alameda, CA
- Signature
- /s/ Jeffrey Rona, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Stelios Papadopoulos:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| EXELIXIS, INC. | Director | Common Stock | 1,189,228 | $51,790,879 | $43.55 | 12 Nov 2025 | Direct |
| BIOGEN INC. | Director | Common Stock | 17,375 | $4,309,000 | $248.00 | 15 Jun 2022 | Stelios Holdings, LLC |
| BIOGEN INC. | Director | Common Stock | 10,831 | $2,686,088 | $248.00 | 15 Jun 2022 | Esperanza Holdings, LLC |
| BIOGEN INC. | Director | Common Stock | 10,095 | $2,503,560 | $248.00 | 15 Jun 2022 | Direct |
| Ovid Therapeutics Inc. | Director | Common Stock | 217,578 | $354,652 | $1.63 | 07 Apr 2026 | Direct |
| Regulus Therapeutics Inc. | Director | Common Stock | 0 | $0 | $7.93 | 25 Jun 2025 | Direct |
| Ovid Therapeutics Inc. | Director | Stock Option (right to buy) | 90,000 | 03 Mar 2025 | Direct | ||
| Ovid Therapeutics Inc. | Director | Employee Stock Option (Right to Buy) | 65,000 | 26 Feb 2026 | Direct | ||
| EXELIXIS, INC. | Director | Option (right to buy) | 0 | 15 May 2025 | Direct | ||
| Regulus Therapeutics Inc. | Director | Common Stock Purchase Warrant (Right to Buy) | 0 | 25 Jun 2025 | Direct | ||
| Regulus Therapeutics Inc. | Director | Stock Option | 0 | 25 Jun 2025 | Direct |
Insider Reports Filed by Stelios Papadopoulos
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | 07 Apr 2026 | 1 | $0 | 4 | Director | 09 Apr 2026, 17:15 |
| OVID | Ovid Therapeutics Inc. | 26 Feb 2026 | 1 | $0 | 4 | Director | 02 Mar 2026, 16:30 |
| EXEL | EXELIXIS, INC. | 12 Nov 2025 | 1 | -$4,355,000 | 4 | Director | 13 Nov 2025, 19:12 |
| RGLS | Regulus Therapeutics Inc. | 25 Jun 2025 | 11 | $0 | 4 | Director | 27 Jun 2025, 17:11 |
| EXEL | EXELIXIS, INC. | 29 May 2025 | 1 | $0 | 4 | Director | 30 May 2025, 19:13 |
| EXEL | EXELIXIS, INC. | 15 May 2025 | 6 | -$885,779 | 4 | Director | 16 May 2025, 20:57 |
| RGLS | Regulus Therapeutics Inc. | 30 Apr 2025 | 1 | $0 | 4 | Director | 30 Apr 2025, 16:30 |
| OVID | Ovid Therapeutics Inc. | 03 Mar 2025 | 1 | $0 | 4 | Director | 04 Mar 2025, 16:44 |
| OVID | Ovid Therapeutics Inc. | 01 Mar 2025 | 0 | $0 | 3 | Director | 04 Mar 2025, 16:42 |
| EXEL | EXELIXIS, INC. | 31 May 2024 | 1 | $0 | 4 | Director | 04 Jun 2024, 20:21 |
| EXEL | EXELIXIS, INC. | 20 May 2024 | 3 | -$11,482 | 4 | Director | 22 May 2024, 19:23 |
| RGLS | Regulus Therapeutics Inc. | 20 May 2024 | 1 | $0 | 4 | Director | 21 May 2024, 16:23 |
| RGLS | Regulus Therapeutics Inc. | 16 May 2024 | 1 | $0 | 4 | Director | 17 May 2024, 16:38 |
| RGLS | Regulus Therapeutics Inc. | 14 Mar 2024 | 1 | +$400,000 | 4 | Director | 15 Mar 2024, 16:19 |
| RGLS | Regulus Therapeutics Inc. | 10 Aug 2023 | 1 | $0 | 4 | Director | 14 Aug 2023, 16:28 |
| RGLS | Regulus Therapeutics Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 13 Jun 2023, 16:50 |
| EXEL | EXELIXIS, INC. | 01 Jun 2023 | 1 | $0 | 4 | Director | 02 Jun 2023, 21:13 |
| RGLS | Regulus Therapeutics Inc. | 13 Apr 2023 | 1 | +$200,000 | 4 | Director | 14 Apr 2023, 16:39 |
| BIIB | BIOGEN INC. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 17:13 |
| RGLS | Regulus Therapeutics Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:18 |
| EXEL | EXELIXIS, INC. | 26 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 21:19 |
| EXEL | EXELIXIS, INC. | 22 Feb 2022 | 1 | -$1,653,113 | 4 | Director | 24 Feb 2022, 19:22 |
| RGLS | Regulus Therapeutics Inc. | 30 Nov 2021 | 1 | +$800,000 | 4 | Director | 01 Dec 2021, 15:12 |
| BIIB | BIOGEN INC. | 01 Jul 2021 | 1 | $0 | 4 | Director | 02 Jul 2021, 17:27 |
| RGLS | Regulus Therapeutics Inc. | 14 Jun 2021 | 1 | $0 | 4 | Director | 15 Jun 2021, 16:43 |
| EXEL | EXELIXIS, INC. | 27 May 2021 | 1 | $0 | 4 | Director | 28 May 2021, 20:26 |
| EXEL | EXELIXIS, INC. | 11 May 2021 | 9 | -$6,394 | 4 | Director | 13 May 2021, 20:32 |